For Oncology Nurses: Oral Selective Estrogen Receptor Degraders in Breast Cancer — Proceedings from the 2026 Annual ONS Congress
Featuring perspectives from Ms Blanca Ledezma, Dr Marissa Marti-Smith, Dr Heather McArthur and Dr Ruth M O'Regan, moderated by Dr McArthur, including the following topics:
- Introduction (0:00)
- Current Clinical Role of Oral Selective Estrogen Receptor Degraders (SERDs) in HR-Positive Metastatic Breast Cancer (3:37)
- Practical Considerations with Oral SERDs (15:42)
- Potential Role of Combination Approaches with Oral SERDs (26:31)
- Gastrointestinal Adverse Events Documented with Oral SERDs (38:17)
- Potential Role of Early Therapeutic Switching After Detection of an Emergent ESR1 Mutation (46:51)
- Other Class-Effect Toxicities Associated with Oral SERDs (1:00:53)
- Emerging Utility of Adjuvant Oral SERDs (1:10:16)
- Unique Toxicities Associated with 1 or More Oral SERDs (1:19:17)
You May Also Like

BrainStuff
iHeartPodcasts

New Books in Public Policy
New Books Network

New Books in Political Science
New Books Network

MinuteEarth
Minute Earth

Something You Should Know
Mike Carruthers | OmniCast Media

BirdNote Daily
BirdNote

Meteor
Český rozhlas

Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio

The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories

Ologies with Alie Ward
Alie Ward
Community discussion